1 Mecobalamin 50 mg or placebo was administered intramuscularly twice weekly for 16 weeks to 130 ALS patients who had suffered from ALS for less than one year, were classified as definite, probable, or probable-laboratory supported according to the Updated Awaji Criteria, had an ALS severity rating of grade 1 or 2, had a decrease of 1 or 2 points in the total score on the Revised ALS Functional Rating Scale-Revised (ALSFRS-R) 12 weeks prior to administration, and had a forced vital capacity (%FVC) of more than 60%
Adjusting the dosage under medical supervision is recommended
Therefore, we are not convinced by the commenter's reason to reassign CPT code 38228 to APC 5242
Its not meant to diagnose or treat any sickness
Not intended for human or animal use or consumption
High Absorption Rate Almost the entire injected dose becomes available to the body, making it highly reliable for severe cases